BMT-i
By Clic-droit
BMT-i is a professional medical assessment battery for evaluating cognitive and learning functions in children, used by speech therapists, psychologists, and occupational therapists on tablet hardware.
The App DNA
What makes this app unique?
The tool provides a shared clinical reference point for multidisciplinary teams to track child development, removing the need for fragmented, single-discipline screening tests.
For Healthcare professionals including speech therapists, occupational therapists, psychologists, and orthoptists managing children with learning disabilities.
Key features
Standardized evaluation tool for speech therapists, occupational therapists, psychologists, and orthoptists.
Conducts clinical evaluations on tablet hardware without requiring an active internet connection during the test session.
Syncs patient evaluation results between tablet hardware and the BMT-i online platform for analysis.
How much does it cost?
Direct sales model for professional medical hardware and software, anchored by a high-cost entry point for clinical practices.
Velocity
Dormant developmentperformanceUX improvementsShow more...
BMT-i shows no signs of active development, with the last update occurring 667 days ago. The release history is extremely sparse, consisting of only two versions across different platforms over a multi-year period. There is no evidence of ongoing maintenance, feature expansion, or operational support for the application.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for BMT-i
How's the Medical market?
BMT-i occupies a specialized niche in the French medical assessment market, serving as a legacy clinical standard. The 667-day update gap signals a shift from active development to a maintenance-only posture, leaving the tool vulnerable to cloud-native entrants.
The rivals identified
The Analyst's Read
Key takeaways for BMT-i
Where is it heading?
The medical assessment market is consolidating around integrated, cloud-native platforms that reduce administrative overhead for clinicians. BMT-i remains exposed due to its legacy architecture and stalled development cadence, which will likely lead to market share erosion as practitioners migrate to tools with faster reporting cycles.
- The 667-day update gap indicates a transition to maintenance-only status, which prevents the tool from addressing modern clinician needs for real-time reporting.
- The reliance on a secondary online platform for final analysis creates a manual workflow that modern cloud-native competitors are actively automating.
The SWOT
- Standardized clinical battery functions as a shared diagnostic language across medical disciplines.
- Offline-first tablet passation ensures clinical continuity in low-connectivity environments.
- Cloud-native reporting integration could eliminate the manual synchronization step currently required for final analysis.
Next best moves
Migrate synchronization to real-time cloud reporting because the current two-step process creates administrative friction → improve clinician retention.
The counter-intuitive read
The tool's lack of cloud-native integration is not just a technical debt…
Read the full takeBottom line
BMT-i serves as a foundational clinical standard, but the lack of active development risks ceding the market to faster, cloud-native assessment platforms. Prioritizing a seamless data pipeline would secure the tool's utility for clinicians who currently face administrative friction.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Developer website, source
- [2] Play Store listing
Report last updated